ExcelMale Member Experiences with Retatrutide
Compiled from forum threads — December 2024 through June 2026
Background
Retatrutide (GLP-3) is a first-in-class triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. It is currently in Eli Lilly's Phase 3 TRIUMPH...